close
MENU
3 mins to read

Hikurangi Cannabis inks multi-million dollar deal

But market supply deal is conditional on New Zealand legislation being passed.

Calida Smylie
Fri, 23 Feb 2018

Hikurangi Cannabis Company, a medical cannabis venture based in Ruatoria, has inked a multi-million dollar deal to produce medical-grade cannabis for the US market.

The company has signed a letter of intent with Seattle-based Rhizo Sciences to produce 3000kg of pharmaceutical-grade cannabis

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Calida Smylie
Fri, 23 Feb 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Hikurangi Cannabis inks multi-million dollar deal
73565
true